Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open...

Por Araki, E., Inagaki, N., Tanizawa, Y., Oura, T., Takeuchi, M., Imaoka, T.
Publicado no Diabetes Obes Metab (2015)

Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial

Por Bekker, Linda-Gail, Roux, Surita, Sebastien, Elaine, Yola, Ntando, Amico, K Rivet, Hughes, James P, Marzinke, Mark A, Hendrix, Craig W, Anderson, Peter L, Elharrar, Vanessa, Stirratt, Michael, Rooney, James F, Piwowar-Manning, Estelle, Eshleman, Susan H, McKinstry, Laura, Li, Maoji, Dye, Bonnie J, Grant, Robert M
Publicado no Lancet HIV (2017)

Telemonitoring of home exercise cycle training in patients with COPD

Por Franke, Karl-Josef, Domanski, Ulrike, Schroeder, Maik, Jansen, Volker, Artmann, Frank, Weber, Uwe, Ettler, Rainer, Nilius, Georg
Publicado no Int J Chron Obstruct Pulmon Dis (2016)

Iron-Magnesium Hydroxycarbonate (Fermagate): A Novel Non-Calcium-Containing Phosphate Binder...

Por McIntyre, Christopher W., Pai, Pearl, Warwick, Graham, Wilkie, Martin, Toft, Alex J., Hutchison, Alastair J.
Publicado em 2009

Luteal phase bleeding after IVF cycles: comparison between progesterone vaginal gel and intramuscular progesterone and correlation with pregnancy outcomes

Por Jabara, Sami, Barnhart, Kurt, Schertz, Joan C, Patrizio, Pasquale
Publicado em 2009

Phase III trial of 8% vaginal progesterone gel for luteal phase support in Japanese women undergoing in vitro fertilization and fresh embryo transfer cycles

Por Kokeguchi, Shoji, Hayashi, Naoki, Rogoff, Daniela, Shimizu, Shin, Ishihara, Osamu
Publicado no Reprod Med Biol (2016)

DOACs vs Vitamin K Antagonists: a Comparison of Phase III Clinical Trials and a Prescriber Support Tool

Por Pirlog, Alina-Maria, Pirlog, Cristian Daniel, Maghiar, Marius Adrian
Publicado no Open Access Maced J Med Sci (2019)

Comparative Effectiveness of Tuberculosis Treatment Daily versus Intermittent Regimen in Indonesian TB-DM Patients: Real World Patient Database Study

Por Angelina Siane, Purwantyastuti Ascobat, Instiaty Instiaty, Heidy Agustin
Publicado em 2020-04-01

Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability

Por Nishio, Shinya, Abe, Mariko, Ito, Hiroyuki
Publicado no Diabetes Metab Syndr Obes (2015)

Pharmacokinetics of Upadacitinib With the Clinical Regimens of the Extended‐Release Formulation Utilized in Rheumatoid Arthritis Phase 3 Trials

Por Mohamed, Mohamed‐Eslam F., Zeng, Jiewei, Marroum, Patrick J., Song, In‐Ho, Othman, Ahmed A.
Publicado no Clin Pharmacol Drug Dev (2018)

Post-injury bladder management strategy influences lower urinary tract dysfunction in the mouse model of spinal cord injury

Por Wada, Naoki, Shimizu, Takahiro, Takai, Shun, Shimizu, Nobutaka, Kanai, Anthony J., Tyagi, Pradeep, Kakizaki, Hidehiro, Yoshimura, Naoki
Publicado no Neurourol Urodyn (2016)

Sequential vs Concurrent Chemoradiation for Stage III Non–Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

Por Curran, Walter J., Paulus, Rebecca, Langer, Corey J., Komaki, Ritsuko, Lee, Jin S., Hauser, Stephen, Movsas, Benjamin, Wasserman, Todd, Rosenthal, Seth A., Gore, Elizabeth, Machtay, Mitchell, Sause, William, Cox, James D.
Publicado em 2011

Edoxaban: An Update on the New Oral Direct Factor Xa Inhibitor

Por Bounameaux, Henri, Camm, A. John
Publicado em 2014

Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co‐formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled...

Por Rodbard, H. W., Cariou, B., Pieber, T. R., Endahl, L. A., Zacho, J., Cooper, J. G.
Publicado no Diabetes Obes Metab (2016)

Ricolinostat, the first selective histone deacetylase 6 inhibitor, in combination with bortezomib and dexamethasone for relapsed or refractory multiple myeloma

Por Vogl, Dan T., Raje, Noopur, Jagannath, Sundar, Richardson, Paul, Hari, Parameswaran, Orlowski, Robert, Supko, Jeffrey G., Tamang, David, Yang, Min, Jones, Simon S., Wheeler, Catherine, Markelewicz, Robert J., Lonial, Sagar
Publicado no Clin Cancer Res (2017)

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

Por Goodman, Andrew D, Bethoux, Francois, Brown, Theodore R, Schapiro, Randall T, Cohen, Ron, Marinucci, Lawrence N, Henney, Herbert R, Blight, Andrew R
Publicado no Mult Scler (2015)

Once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once‐daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks...

Por Odawara, M., Miyagawa, J., Iwamoto, N., Takita, Y., Imaoka, T., Takamura, T.
Publicado no Diabetes Obes Metab (2016)

Effects of intermittent fasting on health markers in those with type 2 diabetes: A pilot study

Por Arnason, Terra G, Bowen, Matthew W, Mansell, Kerry D
Publicado no World J Diabetes (2017)

Review of head‐to‐head comparisons of glucagon‐like peptide‐1 receptor agonists

Por Madsbad, Sten
Publicado no Diabetes Obes Metab (2015)

Functional imaging of subcortical nociceptive structures in response to treatment of chronic daily headache

Por Aurora, Sheena K., Nagesh, Vijaya, Welch, K. Michael A.
Publicado em 2004